nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—female reproductive system—breast cancer	0.00118	0.113	CbGeAlD
Acamprosate—GRM5—endocrine gland—breast cancer	0.001	0.0955	CbGeAlD
Acamprosate—SLC36A1—uterus—breast cancer	0.000689	0.0657	CbGeAlD
Acamprosate—SLC36A1—adipose tissue—breast cancer	0.000674	0.0642	CbGeAlD
Acamprosate—GRIN1—endocrine gland—breast cancer	0.000633	0.0603	CbGeAlD
Acamprosate—SLC36A1—female reproductive system—breast cancer	0.00062	0.059	CbGeAlD
Acamprosate—GRIN2A—adrenal gland—breast cancer	0.000609	0.058	CbGeAlD
Acamprosate—SLC36A1—adrenal gland—breast cancer	0.000605	0.0576	CbGeAlD
Acamprosate—GRIN2B—endocrine gland—breast cancer	0.000604	0.0575	CbGeAlD
Acamprosate—SLC36A1—bone marrow—breast cancer	0.000585	0.0557	CbGeAlD
Acamprosate—SLC36A1—female gonad—breast cancer	0.000564	0.0537	CbGeAlD
Acamprosate—GRIN2A—endocrine gland—breast cancer	0.000528	0.0503	CbGeAlD
Acamprosate—SLC36A1—endocrine gland—breast cancer	0.000524	0.0499	CbGeAlD
Acamprosate—GABRG2—pituitary gland—breast cancer	0.000429	0.0409	CbGeAlD
Acamprosate—SLC36A1—lymph node—breast cancer	0.000363	0.0345	CbGeAlD
Acamprosate—GABRB3—pituitary gland—breast cancer	0.00033	0.0314	CbGeAlD
Acamprosate—GABRB3—female reproductive system—breast cancer	0.000302	0.0287	CbGeAlD
Acamprosate—GABRB3—endocrine gland—breast cancer	0.000255	0.0243	CbGeAlD
Acamprosate—Dermatitis—Gemcitabine—breast cancer	0.000119	0.000168	CcSEcCtD
Acamprosate—Tinnitus—Epirubicin—breast cancer	0.000119	0.000168	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—breast cancer	0.000118	0.000167	CcSEcCtD
Acamprosate—Haemoglobin—Doxorubicin—breast cancer	0.000118	0.000167	CcSEcCtD
Acamprosate—Headache—Gemcitabine—breast cancer	0.000118	0.000167	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000118	0.000167	CcSEcCtD
Acamprosate—Vomiting—Fluorouracil—breast cancer	0.000118	0.000167	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—breast cancer	0.000118	0.000167	CcSEcCtD
Acamprosate—Dyspepsia—Docetaxel—breast cancer	0.000118	0.000167	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—breast cancer	0.000118	0.000166	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—breast cancer	0.000118	0.000166	CcSEcCtD
Acamprosate—Insomnia—Capecitabine—breast cancer	0.000117	0.000166	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—breast cancer	0.000117	0.000165	CcSEcCtD
Acamprosate—Rash—Fluorouracil—breast cancer	0.000117	0.000165	CcSEcCtD
Acamprosate—Dermatitis—Fluorouracil—breast cancer	0.000117	0.000165	CcSEcCtD
Acamprosate—Pharyngitis—Doxorubicin—breast cancer	0.000117	0.000165	CcSEcCtD
Acamprosate—Paraesthesia—Capecitabine—breast cancer	0.000116	0.000165	CcSEcCtD
Acamprosate—Decreased appetite—Docetaxel—breast cancer	0.000116	0.000165	CcSEcCtD
Acamprosate—Hypersensitivity—Paclitaxel—breast cancer	0.000116	0.000165	CcSEcCtD
Acamprosate—Headache—Fluorouracil—breast cancer	0.000116	0.000164	CcSEcCtD
Acamprosate—Oedema peripheral—Doxorubicin—breast cancer	0.000116	0.000164	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—breast cancer	0.000116	0.000164	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Docetaxel—breast cancer	0.000116	0.000163	CcSEcCtD
Acamprosate—Dyspnoea—Capecitabine—breast cancer	0.000116	0.000163	CcSEcCtD
Acamprosate—Nausea—Irinotecan—breast cancer	0.000115	0.000163	CcSEcCtD
Acamprosate—Nausea—Mitoxantrone—breast cancer	0.000115	0.000163	CcSEcCtD
Acamprosate—Immune system disorder—Epirubicin—breast cancer	0.000115	0.000162	CcSEcCtD
Acamprosate—Constipation—Docetaxel—breast cancer	0.000115	0.000162	CcSEcCtD
Acamprosate—Pain—Docetaxel—breast cancer	0.000115	0.000162	CcSEcCtD
Acamprosate—Back pain—Methotrexate—breast cancer	0.000114	0.000162	CcSEcCtD
Acamprosate—Dyspepsia—Capecitabine—breast cancer	0.000114	0.000161	CcSEcCtD
Acamprosate—Chills—Epirubicin—breast cancer	0.000114	0.000161	CcSEcCtD
Acamprosate—Visual impairment—Doxorubicin—breast cancer	0.000113	0.00016	CcSEcCtD
Acamprosate—Asthenia—Paclitaxel—breast cancer	0.000113	0.00016	CcSEcCtD
Acamprosate—Decreased appetite—Capecitabine—breast cancer	0.000113	0.000159	CcSEcCtD
Acamprosate—Alopecia—Epirubicin—breast cancer	0.000112	0.000159	CcSEcCtD
Acamprosate—Nausea—Gemcitabine—breast cancer	0.000112	0.000158	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Capecitabine—breast cancer	0.000112	0.000158	CcSEcCtD
Acamprosate—Pruritus—Paclitaxel—breast cancer	0.000112	0.000158	CcSEcCtD
Acamprosate—Mental disorder—Epirubicin—breast cancer	0.000111	0.000157	CcSEcCtD
Acamprosate—Pain—Capecitabine—breast cancer	0.000111	0.000157	CcSEcCtD
Acamprosate—Constipation—Capecitabine—breast cancer	0.000111	0.000157	CcSEcCtD
Acamprosate—Malnutrition—Epirubicin—breast cancer	0.000111	0.000156	CcSEcCtD
Acamprosate—Feeling abnormal—Docetaxel—breast cancer	0.00011	0.000156	CcSEcCtD
Acamprosate—Nausea—Fluorouracil—breast cancer	0.00011	0.000156	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—breast cancer	0.00011	0.000155	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—breast cancer	0.00011	0.000155	CcSEcCtD
Acamprosate—Gastrointestinal pain—Docetaxel—breast cancer	0.00011	0.000155	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—breast cancer	0.000109	0.000155	CcSEcCtD
Acamprosate—Flatulence—Epirubicin—breast cancer	0.000109	0.000154	CcSEcCtD
Acamprosate—Tension—Epirubicin—breast cancer	0.000109	0.000154	CcSEcCtD
Acamprosate—Dysgeusia—Epirubicin—breast cancer	0.000108	0.000153	CcSEcCtD
Acamprosate—Diarrhoea—Paclitaxel—breast cancer	0.000108	0.000153	CcSEcCtD
Acamprosate—Nervousness—Epirubicin—breast cancer	0.000108	0.000152	CcSEcCtD
Acamprosate—Back pain—Epirubicin—breast cancer	0.000107	0.000151	CcSEcCtD
Acamprosate—Feeling abnormal—Capecitabine—breast cancer	0.000107	0.000151	CcSEcCtD
Acamprosate—Malaise—Methotrexate—breast cancer	0.000107	0.000151	CcSEcCtD
Acamprosate—Muscle spasms—Epirubicin—breast cancer	0.000106	0.00015	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—breast cancer	0.000106	0.00015	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—breast cancer	0.000106	0.00015	CcSEcCtD
Acamprosate—Gastrointestinal pain—Capecitabine—breast cancer	0.000106	0.00015	CcSEcCtD
Acamprosate—Abdominal pain—Docetaxel—breast cancer	0.000106	0.00015	CcSEcCtD
Acamprosate—Body temperature increased—Docetaxel—breast cancer	0.000106	0.00015	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—breast cancer	0.000106	0.00015	CcSEcCtD
Acamprosate—Chills—Doxorubicin—breast cancer	0.000106	0.000149	CcSEcCtD
Acamprosate—Dizziness—Paclitaxel—breast cancer	0.000104	0.000148	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—breast cancer	0.000104	0.000147	CcSEcCtD
Acamprosate—Cough—Methotrexate—breast cancer	0.000103	0.000146	CcSEcCtD
Acamprosate—Mental disorder—Doxorubicin—breast cancer	0.000103	0.000146	CcSEcCtD
Acamprosate—Urticaria—Capecitabine—breast cancer	0.000103	0.000146	CcSEcCtD
Acamprosate—Ill-defined disorder—Epirubicin—breast cancer	0.000103	0.000145	CcSEcCtD
Acamprosate—Body temperature increased—Capecitabine—breast cancer	0.000103	0.000145	CcSEcCtD
Acamprosate—Abdominal pain—Capecitabine—breast cancer	0.000103	0.000145	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—breast cancer	0.000102	0.000145	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—breast cancer	0.000102	0.000145	CcSEcCtD
Acamprosate—Anaemia—Epirubicin—breast cancer	0.000102	0.000145	CcSEcCtD
Acamprosate—Agitation—Epirubicin—breast cancer	0.000102	0.000144	CcSEcCtD
Acamprosate—Flatulence—Doxorubicin—breast cancer	0.000101	0.000143	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—breast cancer	0.000101	0.000142	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—breast cancer	0.000101	0.000142	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—breast cancer	0.000101	0.000142	CcSEcCtD
Acamprosate—Tension—Doxorubicin—breast cancer	0.000101	0.000142	CcSEcCtD
Acamprosate—Vomiting—Paclitaxel—breast cancer	0.0001	0.000142	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—breast cancer	0.0001	0.000142	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.0001	0.000141	CcSEcCtD
Acamprosate—Malaise—Epirubicin—breast cancer	9.98e-05	0.000141	CcSEcCtD
Acamprosate—Rash—Paclitaxel—breast cancer	9.96e-05	0.000141	CcSEcCtD
Acamprosate—Dermatitis—Paclitaxel—breast cancer	9.95e-05	0.000141	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—breast cancer	9.95e-05	0.000141	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—breast cancer	9.95e-05	0.000141	CcSEcCtD
Acamprosate—Vertigo—Epirubicin—breast cancer	9.94e-05	0.000141	CcSEcCtD
Acamprosate—Syncope—Epirubicin—breast cancer	9.93e-05	0.00014	CcSEcCtD
Acamprosate—Leukopenia—Epirubicin—breast cancer	9.91e-05	0.00014	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—breast cancer	9.91e-05	0.00014	CcSEcCtD
Acamprosate—Headache—Paclitaxel—breast cancer	9.9e-05	0.00014	CcSEcCtD
Acamprosate—Hypersensitivity—Docetaxel—breast cancer	9.87e-05	0.000139	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—breast cancer	9.85e-05	0.000139	CcSEcCtD
Acamprosate—Palpitations—Epirubicin—breast cancer	9.78e-05	0.000138	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—breast cancer	9.73e-05	0.000138	CcSEcCtD
Acamprosate—Loss of consciousness—Epirubicin—breast cancer	9.73e-05	0.000138	CcSEcCtD
Acamprosate—Cough—Epirubicin—breast cancer	9.66e-05	0.000137	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—breast cancer	9.65e-05	0.000136	CcSEcCtD
Acamprosate—Asthenia—Docetaxel—breast cancer	9.61e-05	0.000136	CcSEcCtD
Acamprosate—Convulsion—Epirubicin—breast cancer	9.59e-05	0.000136	CcSEcCtD
Acamprosate—Infection—Methotrexate—breast cancer	9.59e-05	0.000136	CcSEcCtD
Acamprosate—Hypertension—Epirubicin—breast cancer	9.56e-05	0.000135	CcSEcCtD
Acamprosate—Hypersensitivity—Capecitabine—breast cancer	9.55e-05	0.000135	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—breast cancer	9.5e-05	0.000134	CcSEcCtD
Acamprosate—Pruritus—Docetaxel—breast cancer	9.48e-05	0.000134	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—breast cancer	9.47e-05	0.000134	CcSEcCtD
Acamprosate—Thrombocytopenia—Methotrexate—breast cancer	9.45e-05	0.000134	CcSEcCtD
Acamprosate—Chest pain—Epirubicin—breast cancer	9.42e-05	0.000133	CcSEcCtD
Acamprosate—Myalgia—Epirubicin—breast cancer	9.42e-05	0.000133	CcSEcCtD
Acamprosate—Arthralgia—Epirubicin—breast cancer	9.42e-05	0.000133	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—breast cancer	9.41e-05	0.000133	CcSEcCtD
Acamprosate—Anxiety—Epirubicin—breast cancer	9.39e-05	0.000133	CcSEcCtD
Acamprosate—Nausea—Paclitaxel—breast cancer	9.39e-05	0.000133	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—breast cancer	9.38e-05	0.000133	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	9.36e-05	0.000132	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—breast cancer	9.33e-05	0.000132	CcSEcCtD
Acamprosate—Discomfort—Epirubicin—breast cancer	9.31e-05	0.000132	CcSEcCtD
Acamprosate—Asthenia—Capecitabine—breast cancer	9.3e-05	0.000132	CcSEcCtD
Acamprosate—Malaise—Doxorubicin—breast cancer	9.24e-05	0.000131	CcSEcCtD
Acamprosate—Dry mouth—Epirubicin—breast cancer	9.22e-05	0.00013	CcSEcCtD
Acamprosate—Vertigo—Doxorubicin—breast cancer	9.2e-05	0.00013	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—breast cancer	9.2e-05	0.00013	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—breast cancer	9.18e-05	0.00013	CcSEcCtD
Acamprosate—Pruritus—Capecitabine—breast cancer	9.17e-05	0.00013	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—breast cancer	9.17e-05	0.00013	CcSEcCtD
Acamprosate—Diarrhoea—Docetaxel—breast cancer	9.16e-05	0.00013	CcSEcCtD
Acamprosate—Confusional state—Epirubicin—breast cancer	9.11e-05	0.000129	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—breast cancer	9.05e-05	0.000128	CcSEcCtD
Acamprosate—Anaphylactic shock—Epirubicin—breast cancer	9.03e-05	0.000128	CcSEcCtD
Acamprosate—Hypotension—Methotrexate—breast cancer	9.02e-05	0.000128	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—breast cancer	9e-05	0.000127	CcSEcCtD
Acamprosate—Infection—Epirubicin—breast cancer	8.97e-05	0.000127	CcSEcCtD
Acamprosate—Cough—Doxorubicin—breast cancer	8.94e-05	0.000126	CcSEcCtD
Acamprosate—Shock—Epirubicin—breast cancer	8.89e-05	0.000126	CcSEcCtD
Acamprosate—Convulsion—Doxorubicin—breast cancer	8.87e-05	0.000125	CcSEcCtD
Acamprosate—Diarrhoea—Capecitabine—breast cancer	8.87e-05	0.000125	CcSEcCtD
Acamprosate—Dizziness—Docetaxel—breast cancer	8.86e-05	0.000125	CcSEcCtD
Acamprosate—Thrombocytopenia—Epirubicin—breast cancer	8.85e-05	0.000125	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—breast cancer	8.84e-05	0.000125	CcSEcCtD
Acamprosate—Tachycardia—Epirubicin—breast cancer	8.82e-05	0.000125	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—breast cancer	8.79e-05	0.000124	CcSEcCtD
Acamprosate—Skin disorder—Epirubicin—breast cancer	8.77e-05	0.000124	CcSEcCtD
Acamprosate—Hyperhidrosis—Epirubicin—breast cancer	8.73e-05	0.000123	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—breast cancer	8.73e-05	0.000123	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—breast cancer	8.72e-05	0.000123	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—breast cancer	8.72e-05	0.000123	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—breast cancer	8.72e-05	0.000123	CcSEcCtD
Acamprosate—Anxiety—Doxorubicin—breast cancer	8.69e-05	0.000123	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—breast cancer	8.67e-05	0.000123	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	8.66e-05	0.000122	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—breast cancer	8.62e-05	0.000122	CcSEcCtD
Acamprosate—Anorexia—Epirubicin—breast cancer	8.61e-05	0.000122	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—breast cancer	8.61e-05	0.000122	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—breast cancer	8.58e-05	0.000121	CcSEcCtD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	8.58e-05	0.000304	CbGpPWpGaD
Acamprosate—Dizziness—Capecitabine—breast cancer	8.58e-05	0.000121	CcSEcCtD
Acamprosate—GRIN2B—Neuronal System—MDM2—breast cancer	8.54e-05	0.000303	CbGpPWpGaD
Acamprosate—Dry mouth—Doxorubicin—breast cancer	8.53e-05	0.000121	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—JUN—breast cancer	8.52e-05	0.000302	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—breast cancer	8.52e-05	0.000302	CbGpPWpGaD
Acamprosate—Vomiting—Docetaxel—breast cancer	8.52e-05	0.00012	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—AKT2—breast cancer	8.51e-05	0.000302	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—RAF1—breast cancer	8.51e-05	0.000302	CbGpPWpGaD
Acamprosate—Dyspepsia—Methotrexate—breast cancer	8.5e-05	0.00012	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FGF10—breast cancer	8.47e-05	0.0003	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CTNNB1—breast cancer	8.46e-05	0.0003	CbGpPWpGaD
Acamprosate—Rash—Docetaxel—breast cancer	8.44e-05	0.000119	CcSEcCtD
Acamprosate—Hypotension—Epirubicin—breast cancer	8.44e-05	0.000119	CcSEcCtD
Acamprosate—Dermatitis—Docetaxel—breast cancer	8.44e-05	0.000119	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—breast cancer	8.43e-05	0.000119	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—breast cancer	8.39e-05	0.000119	CcSEcCtD
Acamprosate—Headache—Docetaxel—breast cancer	8.39e-05	0.000119	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—breast cancer	8.36e-05	0.000118	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—RAF1—breast cancer	8.35e-05	0.000296	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	8.34e-05	0.000296	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Methotrexate—breast cancer	8.33e-05	0.000118	CcSEcCtD
Acamprosate—Infection—Doxorubicin—breast cancer	8.3e-05	0.000117	CcSEcCtD
Acamprosate—Pain—Methotrexate—breast cancer	8.25e-05	0.000117	CcSEcCtD
Acamprosate—Vomiting—Capecitabine—breast cancer	8.24e-05	0.000117	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Epirubicin—breast cancer	8.23e-05	0.000116	CcSEcCtD
Acamprosate—Shock—Doxorubicin—breast cancer	8.22e-05	0.000116	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—breast cancer	8.18e-05	0.000116	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PIK3CD—breast cancer	8.18e-05	0.00029	CbGpPWpGaD
Acamprosate—Rash—Capecitabine—breast cancer	8.18e-05	0.000116	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PDGFA—breast cancer	8.17e-05	0.00029	CbGpPWpGaD
Acamprosate—Insomnia—Epirubicin—breast cancer	8.17e-05	0.000116	CcSEcCtD
Acamprosate—Dermatitis—Capecitabine—breast cancer	8.17e-05	0.000115	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—breast cancer	8.16e-05	0.000115	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—breast cancer	8.16e-05	0.000289	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	8.13e-05	0.000288	CbGpPWpGaD
Acamprosate—Headache—Capecitabine—breast cancer	8.12e-05	0.000115	CcSEcCtD
Acamprosate—Skin disorder—Doxorubicin—breast cancer	8.12e-05	0.000115	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—FGFR1—breast cancer	8.11e-05	0.000288	CbGpPWpGaD
Acamprosate—Paraesthesia—Epirubicin—breast cancer	8.11e-05	0.000115	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—breast cancer	8.08e-05	0.000114	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—breast cancer	8.06e-05	0.000286	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFBR2—breast cancer	8.05e-05	0.000286	CbGpPWpGaD
Acamprosate—Dyspnoea—Epirubicin—breast cancer	8.05e-05	0.000114	CcSEcCtD
Acamprosate—Somnolence—Epirubicin—breast cancer	8.03e-05	0.000114	CcSEcCtD
Acamprosate—Anorexia—Doxorubicin—breast cancer	7.97e-05	0.000113	CcSEcCtD
Acamprosate—Nausea—Docetaxel—breast cancer	7.96e-05	0.000112	CcSEcCtD
Acamprosate—Feeling abnormal—Methotrexate—breast cancer	7.95e-05	0.000112	CcSEcCtD
Acamprosate—Dyspepsia—Epirubicin—breast cancer	7.95e-05	0.000112	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—breast cancer	7.95e-05	0.000282	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ITPR1—breast cancer	7.93e-05	0.000281	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FGFR1—breast cancer	7.91e-05	0.00028	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Methotrexate—breast cancer	7.89e-05	0.000112	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—STAT5A—breast cancer	7.87e-05	0.000279	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB4—breast cancer	7.87e-05	0.000279	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP3—breast cancer	7.87e-05	0.000279	CbGpPWpGaD
Acamprosate—Decreased appetite—Epirubicin—breast cancer	7.85e-05	0.000111	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CB—breast cancer	7.85e-05	0.000278	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TFRC—breast cancer	7.81e-05	0.000277	CbGpPWpGaD
Acamprosate—Hypotension—Doxorubicin—breast cancer	7.81e-05	0.00011	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—LEP—breast cancer	7.8e-05	0.000276	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Epirubicin—breast cancer	7.8e-05	0.00011	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—RAF1—breast cancer	7.74e-05	0.000274	CbGpPWpGaD
Acamprosate—Pain—Epirubicin—breast cancer	7.73e-05	0.000109	CcSEcCtD
Acamprosate—Constipation—Epirubicin—breast cancer	7.73e-05	0.000109	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BRAF—breast cancer	7.72e-05	0.000274	CbGpPWpGaD
Acamprosate—Nausea—Capecitabine—breast cancer	7.7e-05	0.000109	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A2—breast cancer	7.68e-05	0.000272	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TFRC—breast cancer	7.67e-05	0.000272	CbGpPWpGaD
Acamprosate—Urticaria—Methotrexate—breast cancer	7.67e-05	0.000108	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—ERBB2—breast cancer	7.66e-05	0.000272	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—SRC—breast cancer	7.64e-05	0.000271	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—breast cancer	7.64e-05	0.000271	CbGpPWpGaD
Acamprosate—GABRA1—Ion channel transport—RAF1—breast cancer	7.63e-05	0.000271	CbGpPWpGaD
Acamprosate—Body temperature increased—Methotrexate—breast cancer	7.63e-05	0.000108	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—breast cancer	7.63e-05	0.000108	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—SMAD4—breast cancer	7.62e-05	0.00027	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—breast cancer	7.62e-05	0.000108	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—LEP—breast cancer	7.6e-05	0.00027	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1R—breast cancer	7.58e-05	0.000269	CbGpPWpGaD
Acamprosate—Insomnia—Doxorubicin—breast cancer	7.56e-05	0.000107	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—RAF1—breast cancer	7.55e-05	0.000268	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—breast cancer	7.54e-05	0.000267	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MDM2—breast cancer	7.54e-05	0.000267	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCG2—breast cancer	7.52e-05	0.000267	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—NCOA2—breast cancer	7.52e-05	0.000267	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—RAF1—breast cancer	7.51e-05	0.000266	CbGpPWpGaD
Acamprosate—Paraesthesia—Doxorubicin—breast cancer	7.51e-05	0.000106	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—MET—breast cancer	7.48e-05	0.000265	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CDK4—breast cancer	7.48e-05	0.000265	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ERBB2—breast cancer	7.47e-05	0.000265	CbGpPWpGaD
Acamprosate—Dyspnoea—Doxorubicin—breast cancer	7.45e-05	0.000105	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—KDR—breast cancer	7.45e-05	0.000264	CbGpPWpGaD
Acamprosate—Feeling abnormal—Epirubicin—breast cancer	7.44e-05	0.000105	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—HES1—breast cancer	7.44e-05	0.000264	CbGpPWpGaD
Acamprosate—Somnolence—Doxorubicin—breast cancer	7.43e-05	0.000105	CcSEcCtD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MDM2—breast cancer	7.4e-05	0.000262	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NCOR1—breast cancer	7.4e-05	0.000262	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLA2G4A—breast cancer	7.4e-05	0.000262	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Epirubicin—breast cancer	7.39e-05	0.000104	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—NCOA2—breast cancer	7.39e-05	0.000262	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—breast cancer	7.38e-05	0.000262	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—RAF1—breast cancer	7.38e-05	0.000262	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—breast cancer	7.37e-05	0.000261	CbGpPWpGaD
Acamprosate—Dyspepsia—Doxorubicin—breast cancer	7.36e-05	0.000104	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—breast cancer	7.32e-05	0.00026	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF1—breast cancer	7.32e-05	0.000259	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CSF2—breast cancer	7.32e-05	0.000259	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—RAF1—breast cancer	7.3e-05	0.000259	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CDK4—breast cancer	7.29e-05	0.000258	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MET—breast cancer	7.29e-05	0.000258	CbGpPWpGaD
Acamprosate—Decreased appetite—Doxorubicin—breast cancer	7.27e-05	0.000103	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—NRG1—breast cancer	7.27e-05	0.000258	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Doxorubicin—breast cancer	7.22e-05	0.000102	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—HRAS—breast cancer	7.22e-05	0.000256	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—H2AFX—breast cancer	7.21e-05	0.000256	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—breast cancer	7.21e-05	0.000256	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—breast cancer	7.2e-05	0.000255	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NOTCH1—breast cancer	7.2e-05	0.000255	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—breast cancer	7.19e-05	0.000255	CbGpPWpGaD
Acamprosate—Urticaria—Epirubicin—breast cancer	7.18e-05	0.000101	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC5A5—breast cancer	7.17e-05	0.000254	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—E2F1—breast cancer	7.16e-05	0.000254	CbGpPWpGaD
Acamprosate—Pain—Doxorubicin—breast cancer	7.15e-05	0.000101	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—breast cancer	7.15e-05	0.000101	CcSEcCtD
Acamprosate—Body temperature increased—Epirubicin—breast cancer	7.14e-05	0.000101	CcSEcCtD
Acamprosate—Abdominal pain—Epirubicin—breast cancer	7.14e-05	0.000101	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PIK3CB—breast cancer	7.13e-05	0.000253	CbGpPWpGaD
Acamprosate—Hypersensitivity—Methotrexate—breast cancer	7.11e-05	0.000101	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—breast cancer	7.08e-05	0.000251	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—breast cancer	7.06e-05	0.00025	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC5A5—breast cancer	7.05e-05	0.00025	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK3—breast cancer	7.04e-05	0.00025	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—breast cancer	7.02e-05	0.000249	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NOTCH1—breast cancer	7.02e-05	0.000249	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.93e-05	0.000246	CbGpPWpGaD
Acamprosate—Asthenia—Methotrexate—breast cancer	6.93e-05	9.79e-05	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—BRAF—breast cancer	6.89e-05	0.000244	CbGpPWpGaD
Acamprosate—Feeling abnormal—Doxorubicin—breast cancer	6.89e-05	9.74e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—SPP1—breast cancer	6.88e-05	0.000244	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—JUN—breast cancer	6.86e-05	0.000243	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—breast cancer	6.85e-05	0.000243	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Doxorubicin—breast cancer	6.84e-05	9.66e-05	CcSEcCtD
Acamprosate—Pruritus—Methotrexate—breast cancer	6.83e-05	9.65e-05	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	6.81e-05	0.000241	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB3—breast cancer	6.81e-05	0.000241	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.8e-05	0.000241	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGFR2—breast cancer	6.8e-05	0.000241	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—BRAF—breast cancer	6.77e-05	0.00024	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—HRAS—breast cancer	6.71e-05	0.000238	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TFRC—breast cancer	6.71e-05	0.000238	CbGpPWpGaD
Acamprosate—Hypersensitivity—Epirubicin—breast cancer	6.66e-05	9.41e-05	CcSEcCtD
Acamprosate—Urticaria—Doxorubicin—breast cancer	6.64e-05	9.39e-05	CcSEcCtD
Acamprosate—Abdominal pain—Doxorubicin—breast cancer	6.61e-05	9.34e-05	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—breast cancer	6.61e-05	9.34e-05	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—breast cancer	6.6e-05	9.34e-05	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—MMP9—breast cancer	6.57e-05	0.000233	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—breast cancer	6.55e-05	0.000232	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TERT—breast cancer	6.52e-05	0.000231	CbGpPWpGaD
Acamprosate—Asthenia—Epirubicin—breast cancer	6.48e-05	9.16e-05	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MDM2—breast cancer	6.47e-05	0.000229	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—NCOA2—breast cancer	6.46e-05	0.000229	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—RAF1—breast cancer	6.45e-05	0.000229	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT2—breast cancer	6.44e-05	0.000228	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—breast cancer	6.4e-05	0.000227	CbGpPWpGaD
Acamprosate—Pruritus—Epirubicin—breast cancer	6.39e-05	9.04e-05	CcSEcCtD
Acamprosate—Dizziness—Methotrexate—breast cancer	6.38e-05	9.02e-05	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—NCOA1—breast cancer	6.34e-05	0.000225	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGFR1—breast cancer	6.33e-05	0.000225	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT2—breast cancer	6.28e-05	0.000223	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—breast cancer	6.27e-05	0.000222	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HIF1A—breast cancer	6.24e-05	0.000221	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—breast cancer	6.24e-05	0.000221	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—NCOA1—breast cancer	6.22e-05	0.000221	CbGpPWpGaD
Acamprosate—Diarrhoea—Epirubicin—breast cancer	6.18e-05	8.74e-05	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLG—breast cancer	6.18e-05	0.000219	CbGpPWpGaD
Acamprosate—Hypersensitivity—Doxorubicin—breast cancer	6.16e-05	8.71e-05	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.16e-05	0.000218	CbGpPWpGaD
Acamprosate—Vomiting—Methotrexate—breast cancer	6.14e-05	8.68e-05	CcSEcCtD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—breast cancer	6.11e-05	0.000217	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—breast cancer	6.09e-05	0.000216	CbGpPWpGaD
Acamprosate—Rash—Methotrexate—breast cancer	6.09e-05	8.6e-05	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—breast cancer	6.08e-05	8.6e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—MMP2—breast cancer	6.08e-05	0.000216	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLG—breast cancer	6.06e-05	0.000215	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—SRC—breast cancer	6.06e-05	0.000215	CbGpPWpGaD
Acamprosate—Headache—Methotrexate—breast cancer	6.05e-05	8.55e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CAV1—breast cancer	6.03e-05	0.000214	CbGpPWpGaD
Acamprosate—Asthenia—Doxorubicin—breast cancer	6e-05	8.48e-05	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—breast cancer	5.99e-05	0.000212	CbGpPWpGaD
Acamprosate—Dizziness—Epirubicin—breast cancer	5.97e-05	8.45e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—KDR—breast cancer	5.97e-05	0.000211	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A1—breast cancer	5.95e-05	0.000211	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BRAF—breast cancer	5.92e-05	0.00021	CbGpPWpGaD
Acamprosate—Pruritus—Doxorubicin—breast cancer	5.91e-05	8.36e-05	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—SRC—breast cancer	5.9e-05	0.000209	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—breast cancer	5.9e-05	0.000209	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ESR1—breast cancer	5.81e-05	0.000206	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MDM2—breast cancer	5.78e-05	0.000205	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—RAF1—breast cancer	5.76e-05	0.000204	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—breast cancer	5.75e-05	0.000204	CbGpPWpGaD
Acamprosate—Vomiting—Epirubicin—breast cancer	5.74e-05	8.12e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FN1—breast cancer	5.74e-05	0.000204	CbGpPWpGaD
Acamprosate—Nausea—Methotrexate—breast cancer	5.73e-05	8.11e-05	CcSEcCtD
Acamprosate—Diarrhoea—Doxorubicin—breast cancer	5.72e-05	8.08e-05	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—breast cancer	5.7e-05	0.000202	CbGpPWpGaD
Acamprosate—Rash—Epirubicin—breast cancer	5.7e-05	8.05e-05	CcSEcCtD
Acamprosate—Dermatitis—Epirubicin—breast cancer	5.69e-05	8.04e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—NFKBIA—breast cancer	5.67e-05	0.000201	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MDM2—breast cancer	5.67e-05	0.000201	CbGpPWpGaD
Acamprosate—Headache—Epirubicin—breast cancer	5.66e-05	8e-05	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—RAF1—breast cancer	5.65e-05	0.0002	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH1—breast cancer	5.62e-05	0.000199	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—breast cancer	5.6e-05	0.000198	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK3—breast cancer	5.58e-05	0.000198	CbGpPWpGaD
Acamprosate—Dizziness—Doxorubicin—breast cancer	5.53e-05	7.81e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—RAF1—breast cancer	5.52e-05	0.000196	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—HRAS—breast cancer	5.51e-05	0.000195	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	5.5e-05	0.000195	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RELA—breast cancer	5.5e-05	0.000195	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CG—breast cancer	5.5e-05	0.000195	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KIT—breast cancer	5.5e-05	0.000195	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APC—breast cancer	5.5e-05	0.000195	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB1—breast cancer	5.47e-05	0.000194	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ERBB2—breast cancer	5.47e-05	0.000194	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK3—breast cancer	5.44e-05	0.000193	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—NCOA1—breast cancer	5.44e-05	0.000193	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGF—breast cancer	5.43e-05	0.000193	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	5.4e-05	0.000192	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RAF1—breast cancer	5.39e-05	0.000191	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—breast cancer	5.38e-05	0.000191	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB1—breast cancer	5.37e-05	0.00019	CbGpPWpGaD
Acamprosate—Nausea—Epirubicin—breast cancer	5.37e-05	7.59e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—RELA—breast cancer	5.36e-05	0.00019	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ERBB2—breast cancer	5.33e-05	0.000189	CbGpPWpGaD
Acamprosate—Vomiting—Doxorubicin—breast cancer	5.31e-05	7.51e-05	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—EGFR—breast cancer	5.31e-05	0.000188	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLG—breast cancer	5.3e-05	0.000188	CbGpPWpGaD
Acamprosate—Rash—Doxorubicin—breast cancer	5.27e-05	7.45e-05	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—breast cancer	5.27e-05	7.44e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—MAPK3—breast cancer	5.26e-05	0.000187	CbGpPWpGaD
Acamprosate—Headache—Doxorubicin—breast cancer	5.24e-05	7.4e-05	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—EGFR—breast cancer	5.18e-05	0.000183	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BRAF—breast cancer	5.17e-05	0.000183	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—breast cancer	5.14e-05	0.000182	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—breast cancer	5.03e-05	0.000178	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT2—breast cancer	5.03e-05	0.000178	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KRAS—breast cancer	5.02e-05	0.000178	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—breast cancer	5.01e-05	0.000177	CbGpPWpGaD
Acamprosate—Nausea—Doxorubicin—breast cancer	4.97e-05	7.02e-05	CcSEcCtD
Acamprosate—GABRA1—Neuronal System—MDM2—breast cancer	4.96e-05	0.000176	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—RAF1—breast cancer	4.94e-05	0.000175	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—breast cancer	4.89e-05	0.000173	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KRAS—breast cancer	4.89e-05	0.000173	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CD—breast cancer	4.83e-05	0.000171	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—HRAS—breast cancer	4.8e-05	0.00017	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—breast cancer	4.79e-05	0.00017	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CTNNB1—breast cancer	4.78e-05	0.00017	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—breast cancer	4.78e-05	0.000169	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—breast cancer	4.75e-05	0.000168	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KRAS—breast cancer	4.73e-05	0.000168	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	4.72e-05	0.000167	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB1—breast cancer	4.7e-05	0.000166	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—breast cancer	4.69e-05	0.000166	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HRAS—breast cancer	4.68e-05	0.000166	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CTNNB1—breast cancer	4.66e-05	0.000165	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—breast cancer	4.57e-05	0.000162	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—breast cancer	4.56e-05	0.000162	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—breast cancer	4.35e-05	0.000154	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MDM2—breast cancer	4.33e-05	0.000153	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SRC—breast cancer	4.32e-05	0.000153	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RAF1—breast cancer	4.31e-05	0.000153	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RELA—breast cancer	4.29e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB2—breast cancer	4.27e-05	0.000151	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—breast cancer	4.26e-05	0.000151	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SRC—breast cancer	4.21e-05	0.000149	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MTOR—breast cancer	4.21e-05	0.000149	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CB—breast cancer	4.21e-05	0.000149	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—breast cancer	4.21e-05	0.000149	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—breast cancer	4.17e-05	0.000148	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—breast cancer	4.16e-05	0.000147	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—breast cancer	4.15e-05	0.000147	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—breast cancer	4.14e-05	0.000147	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—breast cancer	4.1e-05	0.000145	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—breast cancer	4.08e-05	0.000145	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—breast cancer	4.06e-05	0.000144	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—breast cancer	4.06e-05	0.000144	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—breast cancer	4.05e-05	0.000143	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—breast cancer	4.02e-05	0.000143	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK3—breast cancer	3.98e-05	0.000141	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—breast cancer	3.98e-05	0.000141	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1B—breast cancer	3.95e-05	0.00014	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—breast cancer	3.91e-05	0.000139	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK3—breast cancer	3.88e-05	0.000138	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—breast cancer	3.87e-05	0.000137	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—breast cancer	3.87e-05	0.000137	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—breast cancer	3.86e-05	0.000137	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—breast cancer	3.85e-05	0.000136	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—breast cancer	3.79e-05	0.000134	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCND1—breast cancer	3.77e-05	0.000134	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—breast cancer	3.77e-05	0.000134	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUN—breast cancer	3.76e-05	0.000133	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CTNNB1—breast cancer	3.73e-05	0.000132	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—breast cancer	3.69e-05	0.000131	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—breast cancer	3.66e-05	0.00013	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1A—breast cancer	3.65e-05	0.000129	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTEN—breast cancer	3.64e-05	0.000129	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—breast cancer	3.61e-05	0.000128	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—breast cancer	3.58e-05	0.000127	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—breast cancer	3.56e-05	0.000126	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—breast cancer	3.55e-05	0.000126	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—breast cancer	3.55e-05	0.000126	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—breast cancer	3.52e-05	0.000125	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KRAS—breast cancer	3.49e-05	0.000124	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—breast cancer	3.42e-05	0.000121	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SRC—breast cancer	3.37e-05	0.00012	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—breast cancer	3.36e-05	0.000119	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—breast cancer	3.29e-05	0.000117	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—breast cancer	3.25e-05	0.000115	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—breast cancer	3.17e-05	0.000112	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—breast cancer	3.11e-05	0.00011	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK3—breast cancer	3.11e-05	0.00011	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—RAF1—breast cancer	3.09e-05	0.00011	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—breast cancer	3.04e-05	0.000108	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—RAF1—breast cancer	3.04e-05	0.000108	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—breast cancer	3.02e-05	0.000107	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—breast cancer	3.02e-05	0.000107	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—breast cancer	2.97e-05	0.000105	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—breast cancer	2.96e-05	0.000105	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—breast cancer	2.94e-05	0.000104	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—breast cancer	2.91e-05	0.000103	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—breast cancer	2.84e-05	0.000101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—breast cancer	2.79e-05	9.9e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—breast cancer	2.72e-05	9.64e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—breast cancer	2.69e-05	9.52e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—RAF1—breast cancer	2.66e-05	9.42e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—breast cancer	2.62e-05	9.28e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—breast cancer	2.57e-05	9.1e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—breast cancer	2.48e-05	8.8e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—breast cancer	2.38e-05	8.42e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—breast cancer	2.27e-05	8.06e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—breast cancer	2.1e-05	7.43e-05	CbGpPWpGaD
